Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032906HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10040510HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS10042489HBVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001392HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001393HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30001394HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30013875HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30088317HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019456HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019457HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB08877
Drug NameRuxolitinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs23514013; 23061804; 21919691
CitationsCervantes F, Martinez-Trillos A: Myelofibrosis: an update on current pharmacotherapy and future directions. Expert Opin Pharmacother. 2013 May;14(7):873-84. doi: 10.1517/14656566.2013.783019. Epub 2013 Mar 21.@@Yang LP, Keating GM: Ruxolitinib: in the treatment of myelofibrosis. Drugs. 2012 Nov 12;72(16):2117-27. doi: 10.2165/11209340-000000000-00000.@@Ostojic A, Vrhovac R, Verstovsek S: Ruxolitinib: a new JAK1/2 inhibitor that offers promising options for treatment of myelofibrosis. Future Oncol. 2011 Sep;7(9):1035-43. doi: 10.2217/fon.11.81.
GroupsApproved
Direct ClassificationPyrrolo[2,3-d]pyrimidines
SMILESN#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Pathways
PharmGKBPA166123386
ChEMBLCHEMBL1789941